Prophylaxis with standard therapeutic factor concentrate vs pegylated liposome FVIII formulation
Any reported adverse effects · children or adults with hemophilia A
1 finding from 1 review
- Clotting factor concentrates for preventing bleeding and bleeding‐related complications in previously treated… 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 143 participantsLow